-
Developing an innovative antibody-based nanopharmaceutical for treating cancer
Read MoreRituximab is an anti-CD20 monoclonal antibody (mAb), approved for use in combination with standard chemotherapeutic agents for treatment of patients with CD20-positive…
-
Developing innovative nanopharmaceuticals for the treatment of relapsed breast cancer
Read MoreTherapeutic antibodies are a popular and effective class of cancer drugs, particularly when combined with more traditional treatments. While natural antibodies are…